Literature DB >> 1745844

Bilateral bronchoalveolar lavage in progressive systemic sclerosis: interlobar variability, lymphocyte subpopulations, and functional correlations.

L Frigieri1, F Mormile, N Grilli, D Mancini, G Ciappi, G Pagliari, M Magarò, G Flamini.   

Abstract

Bilateral bronchoalveolar lavage (BAL) was carried out in right middle and left upper lobes of 22 nonsmoking females suffering from progressive systemic sclerosis in order to assess interlobar differences and functional correlation of the BAL composition. The patients' age ranged from 20 to 66 years, and the mean disease duration was 10.4 years. The most frequent finding was a mild BAL lymphocytosis (right in 11 of 22 patients; left in 8 of 22), but eosinophilic (right in 11 of 22; left in 5 of 22 patients) and neutrophilic (right in 9 of 22 patients; left in 1 of 22) alveolitis was recognized as well. Differential counts suggestive of alveolitis limited to one of the lavaged lobes were demonstrated in about one fourth of the cases. Including increased cellularity among the criteria of pathological BAL fluid composition, 14% of the subjects showed bilateral BAL results within the normal range. OKT8-positive lymphocytes were significantly increased in 3 patients, but the mean values were not. Total lung capacity, vital capacity, and forced expiratory volume in 1 s correlated inversely with BAL neutrophil (p less than 0.05) and granulocytic (p less than 0.01) differential counts; the strongest, positive correlation was demonstrated regarding the lymphocyte/granulocyte ratios (p less than 0.0005). In conclusion, several patterns of alveolitis as well as a bilaterally normal BAL composition were found in our series; moreover, even if inhomogeneous alveolitis did occur, a single lavage performed in the right middle lobe correctly detected or excluded the presence of an alveolitis in 95% of our patients.

Entities:  

Mesh:

Year:  1991        PMID: 1745844     DOI: 10.1159/000195913

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  7 in total

Review 1.  Immunophenotyping of bronchoalveolar lavage lymphocytes.

Authors:  R J Harbeck
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

2.  Spontaneous pneumothorax in a patient with systemic sclerosis.

Authors:  M Zeuner; U Müller-Ladner; V D Mohr; B Lang
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

3.  Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.

Authors:  B Gudbjörnsson; R Hällgren; O Nettelbladt; R Gustafsson; A Mattsson; E af Geijerstam; T H Tötterman
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

4.  Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.

Authors:  M R Hussein; H I Hassan; E R M Hofny; M Elkholy; N A Fatehy; A E A Abd Elmoniem; A M Ezz El-Din; O A Afifi; H G Rashed
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

5.  Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung disease.

Authors:  Kazumasa Kase; Satoshi Watanabe; Keigo Saeki; Yuko Waseda; Hazuki Takato; Yukari Ichikawa; Akari Murata; Masahide Yasui; Ohkura Noriyuki; Johsuke Hara; Takashi Sone; Miki Abo; Hideharu Kimura; Kazuo Kasahara
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

6.  Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration.

Authors:  Hidekata Yasuoka; Zhihong Zhou; Joseph M Pilewski; Tim D Oury; Augustine M K Choi; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

7.  The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration.

Authors:  Hidekata Yasuoka; Yukie Yamaguchi; Carol A Feghali-Bostwick
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-08       Impact factor: 6.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.